ESTEVE APPOINTS JORDI MUNTAÑOLA AS CHIEF COMMERCIAL OFFICER FOR EUROPE
Jordi Muntañola will take on the leadership of all the pharmaceutical activities in Spain and Europe
ESTEVE has appointed Jordi Muntañola as the new Chief Commercial Officer for Europe, taking on the leadership of all the pharmaceutical activities in Spain and Europe. Dr. Muntañola takes over from Joe Sullivan, who remains at the company for a few months facilitating a smooth transition.
Born in 1978 in Barcelona, Jordi Muntañola holds a PhD in Molecular Biology from the University of Navarra and an MBA from ESADE. He has broad experience in the healthcare sector at companies such as the Werfen Group and Esaote, among others. Throughout his career, Dr. Muntañola has formed part of and managed teams of R&D, Corporate Strategy, Business Development, Operations and Business Management, and has headed Business Transformation projects in Spain as well as internationally.
Jordi Muntañola joined ESTEVEs team in 2016 as Director of Pharma Operational Excellence, a responsibility to which, at a later stage, the Management of the Consumer Care Division was added.
THE PROGRAM ’PLAN PROFARMA’ HAS ONCE AGAIN QUALIFIED ESTEVE’S R&D&I AS ’’EXCELLENT’’
Once again, ESTEVE's research activity has received the qualification ''Excellent'' in the Program 'Plan Profarma' (Program for Fostering Scientific Research, Technological Development and Innovation ...read more
PENSA PHARMA HAS BEEN AWARDED A PRIZE FOR ITS BEST DEVELOPMENT AND COMMERCIALIZATION OF GENERIC MEDICINES
Pensa Pharma (PENSA), a company of the ESTEVE Group specialized in generic medicines, has been awarded a prize at the II edition of La Razón Comunidad Valenciana Awards. Specifically, PENSA has receiv...read more
ESTEVE APPOINTS THOMAS B. RIISAGER AS CHIEF CORPORATE STRATEGY & BUSINESS DEVELOPMENT OFFICER
ESTEVE has announced today the appointment of Thomas B Riisager as Chief Corporate Strategy & Business Development Officer, to be heading Corporate Strategy & Business Development for the pharmaceutic...read more